A study in humans identified the mir-6885-3p as a potential biomarker selected from RNA-seq for validation based on an area under the curve greater than 0.6 or involvement in plaque rupture or erosion mechanisms in patients with ST-segment elevation myocardial infarction [Li et al. DOI:10.1016/j.ygeno.2020.11.019].